HighTower Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,717
Closed -$386K 3919
2024
Q2
$386K Buy
18,717
+102
+0.5% +$2.21K ﹤0.01% 2512
2024
Q1
$459K Sell
18,615
-120
-0.6% -$3.57K ﹤0.01% 2334
2023
Q4
$680K Buy
+18,735
New +$721K ﹤0.01% 2096
2023
Q3
Sell
-3,781
Closed -$263K 3717
2023
Q2
$263K Buy
+3,781
New +$244K ﹤0.01% 2653
2022
Q2
Sell
-7,820
Closed -$286K 3476
2022
Q1
$286K Buy
+7,820
New +$282K ﹤0.01% 2564
2015
Q4
Sell
-5,590
Closed -$255K 2117
2015
Q3
$255K Buy
+5,590
New +$326K ﹤0.01% 1535

Other funds holding PRTA

HighTower Advisors's PRTA Position: Q3 2024 in Review

HighTower Advisors sold out of Prothena Corp (PRTA) in Q3 2024, closing a stake of 18,717 shares — an estimated $386K sold.

HighTower Advisors first reported a position in PRTA in Q3 2015 and held it in 6 quarters. The position peaked at $680K in Q4 2023. 164 funds tracked by Wall St. Rank hold PRTA as of Q3 2024.

  • HighTower Advisors reported no remaining Prothena Corp position as of Q3 2024 after selling out during the quarter.
  • HighTower Advisors sold 18,717 Prothena Corp shares in Q3 2024, an estimated $386K.
  • HighTower Advisors first reported a position in Prothena Corp in Q3 2015 and held it in 6 quarters.
  • HighTower Advisors's Prothena Corp position peaked at $680K in Q4 2023.
  • 164 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2024.

Based on HighTower Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.